New method to differentiate human peripheral blood monocytes into insulin producing cells: Human hematosphere culture

Biochemical and Biophysical Research Communications

Volumn 418, Issue 4, 2012, Pages 765-769

  Hur, Jin ^a,b   Yang, Ji Min ^a,b   Choi, Jae Il ^a,b   Yun, Ji Yeon ^a,b   Jang, Jae Hee ^a,b   Kim, Joonoh ^a,b   Kim, Ju Young ^a,b   Oh, Il Young ^a,b,c   Yoon, Chang Hwan ^a,c   Cho, Hyun Jai ^a,b   Park, Young Bae ^b   Kim, Hyo Soo ^a,b  

^a National Research Laboratory for Stem Cell Niche   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Insulin; Insulin producing cells; Regenerative medicine; Spheroid; Stem cells; Three dimensional culture

Indexed keywords

BETA TUBULIN; DITHIZONE; FIBRONECTIN; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; NESTIN; NEUROGENIN 3; SULFONYLUREA RECEPTOR 1; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PDX 1; ZINC ION;

ARTICLE; BLOOD BORN HEMATOSPHERE; BLOOD CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN BINDING; INSULIN RELEASE; INSULIN RESPONSE; MONOCYTE; NORMAL HUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; INSULIN; INSULIN-SECRETING CELLS; INTERMEDIATE FILAMENT PROTEINS; MONOCYTES; NERVE TISSUE PROTEINS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TUBULIN;

EID: 84862809136     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.096     Document Type: Article

References (19)

1. Devendra D., Liu E., Eisenbarth G.S. Type 1 diabetes: recent developments. BMJ 2004, 328:750-754.
2. Park H.W., Kown T.G., Kim K.Y., Bae J.H. Diabetes, insulin resistance and atherosclerosis surrogates in patients with coronary atherosclerosis. Korean Circ. J. 2010, 40:62-67.
3. Jones P.M., Courtney M.L., Burns C.J., Persaud S.J. Cell-based treatments for diabetes. Drug. Discov. Today. 2008, 13:888-893.
4. Taylor C.J., Bolton E.M., Bradley J.A. Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos. Trans. R Soc. Lond. B Biol. Sci. 2011, 366:2312-2322.
5. Byun K.H., Kim S.W. Is stem cell-based therapy going on or out for cardiac disease?. Korean Circ. J. 2009, 39:87-92.
6. Boyd A.S., Wood K.J. Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters. PLoS ONE 2010, 5:e10965.
7. Tuch B.E., Hughes T.C., Evans M.D. Encapsulated pancreatic progenitors derived from human embryonic stem cells as a therapy for insulin-dependent diabetes. Diabetes Metab. Res. Rev. 2011, 27:928-932.
8. Motoyama H., Ogawa S., Kubo A., Miwa S., Nakayama J., Tagawa Y., Miyagawa S. In vitro reprogramming of adult hepatocytes into insulin-producing cells without viral vectors. Biochem. Biophys. Res. Commun. 2009, 385:123-128.
9. Hur J., Park J., Lee S.E., Yoon C.H., Jang J.H., Yang J.M., Lee T.K., Choi J.I., Yang H.M., Lee E.J., Cho H.J., Kang H.J., Oh B.H., Park Y.B., Kim H.S. Human peripheral blood-born hematosphere as a niche for hematopoietic stem cell expansion. Cell Res. 2011, 21:987-990.
10. Hur J., Yang H.M., Yoon C.H., Lee C.S., Park K.W., Kim J.H., Kim T.Y., Kim J.Y., Kang H.J., Chae I.H., Oh B.H., Park Y.B., Kim H.S. Identification of a novel role of T cells in postnatal vasculogenesis - Characterization of endothelial progenitor cell colonies. Circulation 2007, 116:1671-1682.
11. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., Oh B.H., Lee M.M., Park Y.B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
12. Hori Y., Gu X., Xie X., Kim S.K. Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med. 2005, 2:e103.
13. Hohmeier H.E., Mulder H., Chen G., Henkel-Rieger R., Prentki M., Newgard C.B. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000, 49:424-430.
14. Bond J.F., Robinson G.S., Farmer S.R. Differential expression of two neural cell-specific beta-tubulin mRNAs during rat brain development. Mol. Cell. Biol. 1984, 4:1313-1319.
15. Drapeau J., El-Helou V., Clement R., Bel-Hadj S., Gosselin H., Trudeau L.E., Villeneuve L., Calderone A. Nestin-expressing neural stem cells identified in the scar following myocardial infarction. J. Cell. Physiol. 2005, 204:51-62.
16. Chang C.F., Hsu K.H., Chiou S.H., Ho L.L., Fu Y.S., Hung S.C. Fibronectin and pellet suspension culture promote differentiation of human mesenchymal stem cells into insulin producing cells. J. Biomed. Mater Res. A 2008, 86:1097-1105.
17. Narendran P., Neale A.M., Lee B.H., Ngui K., Steptoe R.J., Morahan G., Madsen O., Dromey J.A., Jensen K.P., Harrison L.C. Proinsulin is encoded by an RNA splice variant in human blood myeloid cells. Proc. Natl. Acad Sci. USA 2006, 103:16430-16435.
18. Tomar G.B., Srivastava R.K., Gupta N., Barhanpurkar A.P., Pote S.T., Jhaveri H.M., Mishra G.C., Wani M.R. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem. Biophys. Res. Commun. 2010, 393:377-383.
19. Nelson T.J., Martinez-Fernandez A., Yamada S., Ikeda Y., Perez-Terzic C., Terzic A. Induced pluripotent stem cells: advances to applications. Stem Cells Cloning 2010, 3:29-37.